Morepen Laboratories Ltd
Sushil Suri serves as the Chairman and Managing Director of Morepen Laboratories Limited India, where Suri has been active since April 1992, overseeing operations in pharmaceuticals, APIs, finished dosages, medical devices, and biotech. Additionally, Suri is the Founder of Morepen Bio, Inc. since October 2022, focusing on innovative biosimilars. In April 2001, Suri established DR. MOREPEN LIMITED, an exclusive lifestyle OTC brand targeting health and wellness markets. Suri previously held the role of Chairman & Managing Director at Blue Coast Hotels Ltd from March 2015 to September 2018. Educational credentials include a Certified Online Course in Digital Transformation from the University of California, Berkeley in 2019, and a CA in Accounts & Finance from DAV College Chandigarh.
This person is not in the org chart
This person is not in any offices
Morepen Laboratories Ltd
Morepen Laboratories Limited is a pharmaceutical company. The Company's divisions include Active Pharmaceutical Ingredients (API), Home Diagnostics and Finished Formulations. The API division offers products, such as Loratadine Process-1, Desloratadine, Atorvastatin Calcium Amorphous, Atorvastatin Calcium Crystalline Form VI and Linagliptin, among others. The Company offers products under the self-health diagnostic brand HomeHealth. Its HomeHealth portfolio includes automatic digital blood pressure monitors, digital and analog weighing scales, body and foot massagers, heat therapy range, nebulizers, pregnancy cards, and clinical and digital thermometers. The Company offers no coding blood glucose monitoring system under its brand, GlucoOne. It markets various brands of medical devices and clinical diagnostic products. The Company operates in India, the United States and Rest of World. Its subsidiaries include Dr. Morepen Limited, Total Care Limited and Morepen Inc.